Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Omentin-1 Level in Psoriatic Patients Treated With Narrowband Ultraviolet B Phototherapy Versus Acitretin

NCT05203354 is registered in ClinicalTrials.gov with Mahmoud Ahmed Ali Ahmed as lead sponsor.

NCT NCT05203354
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05203354 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Omentin-1 Level in Psoriatic Patients Treated With Narrowband Ultraviolet B Phototherapy Versus Acitretin
Lead sponsor
Mahmoud Ahmed Ali Ahmed
Phase
Phase 4
Overall status
Completed
Start date
September 1, 2018
Completion date
August 15, 2021
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis